Skip to main content
Top
Published in: Clinical and Translational Oncology 3/2007

01-03-2007 | Erratum

Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck Carcinoma

Authors: Fernando Rivera, María E Vega-Villegas, Marta F. López-Brea, Almudena García-Castaño, Ana de Juan, Francisco Javier Ramos, Antonio Collado, Piedad Galdós, Antonio Rubio, Adolfo del Valle, Julio Rama, Marta Mayorga, Jaime Sanz-Ortiz

Published in: Clinical and Translational Oncology | Issue 3/2007

Login to get access
Metadata
Title
Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck Carcinoma
Authors
Fernando Rivera
María E Vega-Villegas
Marta F. López-Brea
Almudena García-Castaño
Ana de Juan
Francisco Javier Ramos
Antonio Collado
Piedad Galdós
Antonio Rubio
Adolfo del Valle
Julio Rama
Marta Mayorga
Jaime Sanz-Ortiz
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 3/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0038-z

Other articles of this Issue 3/2007

Clinical and Translational Oncology 3/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine